Skip to main content

Migraine clinical trials at UCSD

3 in progress, 2 open to eligible people

Showing trials for
  • PIVOTAL STUDY EVALUATING SAFETY and EFFICACY of the SHIRATRONICS MIGRAINE THERAPY SYSTEM

    open to eligible people ages 22 years and up

    Prospective, multi-center, double blind, randomized, sham-controlled study to evaluate neuromodulation in patient with chronic migraine. The study hypothesis to be tested is the mean reduction in mean monthly headache days between patients in treatment versus sham.

    La Jolla, California and other locations

  • Children and Adolescents With Migraine: Acute Treatment

    open to eligible people ages 6-17

    The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.

    La Jolla, California and other locations

  • Inhaled Cannabis for Acute Migraine Treatment

    Sorry, currently not accepting new patients, but might later

    This pilot crossover study will evaluate 3 different potencies of inhaled cannabis (2.5%, 5%, and 10%) and inhaled placebo cannabis for the acute treatment of migraine.

    La Jolla, California

Our lead scientists for Migraine research studies include .

Last updated: